OraSure Technologies

OraSure Technologies

Health Care Equipment & Supplies
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

$263.5M

Market Cap • 9/29/2026

2000

(26 years)

Founded

1986

(40 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

0,8

P/S

2,3

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

4,5

EPS

—

Market Cap

Market Cap

263,5M

EV

115M

EV/Revenue

1

EV/EBITDA

-2,6

EV/EBIT

-2,1

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

7,1%

Total Yield

7,1%

Payout

0%

Retained Earnings

-188,3M

Profitability

Gross Margin

42,6%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

39,7%

Capex/Revenue

4,6%

Capex/D&A

54,1%

Capex/OCF

-12,1%

SBC/OCF

—

% PPE

13,8%

% Goodwill

11,8%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

-13,1%

Leverage

N.D./EBITDA

3,4

Debt/Equity

0%

Current Ratio

8,9

Quick Ratio

7,5

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium